Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes [[electronic resource]]
| An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes [[electronic resource]] |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. G.P.O.], , [2012] |
| Descrizione fisica | 1 online resource (140 unnumbered pages) |
| Soggetto topico |
Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States Medical instruments and apparatus - Prices - United States Generic drugs - Prices - United States User charges - Law and legislation - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910702028003321 |
| [Washington, D.C.] : , : [U.S. G.P.O.], , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes
| An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , 2017 |
| Descrizione fisica | 1 online resource (86 unnumbered pages) |
| Soggetto topico |
Drugs - Prices - Law and legislation - United States
Prescription pricing - Law and legislation - United States Medical instruments and apparatus industry - Law and legislation - United States Generic drugs - Prices - United States Biologicals - Law and legislation - United States User charges - Law and legislation - United States |
| Soggetto genere / forma | Statutes and codes. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910706512203321 |
| [Washington, D.C.] : , : [U.S. Government Publishing Office], , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period / / Luke M. Olson, Brett W. Wendling
| The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period / / Luke M. Olson, Brett W. Wendling |
| Autore | Olson Luke M. |
| Pubbl/distr/stampa | Washington, DC : , : Bureau of Economics, Federal Trade Commission, , 2013 |
| Descrizione fisica | 1 online resource (41 unnumbered pages) : illustrations |
| Collana | Working paper |
| Soggetto topico |
Generic drugs - Economic aspects - United States
Generic drugs - Prices - United States Drugs - Prices - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910704009603321 |
Olson Luke M.
|
||
| Washington, DC : , : Bureau of Economics, Federal Trade Commission, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Entry threats and pricing in the generic drug industry [[electronic resource] /] / Brett Wendling, Steven Tenn
| Entry threats and pricing in the generic drug industry [[electronic resource] /] / Brett Wendling, Steven Tenn |
| Autore | Wendling Brett |
| Pubbl/distr/stampa | Washington, DC : , : Bureau of Economics, Federal Trade Commission, , [2010] |
| Descrizione fisica | 1 online resource (27 pages) : digital, PDF file |
| Altri autori (Persone) | TennSteven |
| Collana | Working paper |
| Soggetto topico |
Generic drugs - Prices - United States
Pharmaceutical industry - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910699567003321 |
|
Wendling Brett
|
||
| Washington, DC : , : Bureau of Economics, Federal Trade Commission, , [2010] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
| Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2018 |
| Descrizione fisica | 1 online resource (v, 136 pages) : illustrations |
| Soggetto topico |
User charges - Law and legislation
Prescription pricing - Law and legislation Generic drugs - Prices Drugs - Law and legislation Generic drugs - Prices - United States Prescription pricing - Law and legislation - United States User charges - Law and legislation - United States Drug accessibility - Government policy - United States Drugs - Law and legislation - United States |
| Soggetto genere / forma |
Rules.
Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Examining FDA's generic drug and biosimilar user fee programs |
| Record Nr. | UNINA-9910716666403321 |
| Washington : , : U.S. Government Publishing Office, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
| Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2018 |
| Descrizione fisica | 1 online resource (v, 107 pages) : illustrations |
| Soggetto topico |
User charges - Law and legislation - United States
Drugs - Law and legislation - United States Prescription pricing - Law and legislation - United States Generic drugs - Prices - United States Drug accessibility - Government policy - United States Drug approval - United States |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Examining FDA's Prescription Drug User Fee program |
| Record Nr. | UNINA-9910706847203321 |
| Washington : , : U.S. Government Publishing Office, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Expanding the use of generic drugs
| Expanding the use of generic drugs |
| Pubbl/distr/stampa | Washington, DC : , : Office of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services, , 2010 |
| Descrizione fisica | 1 online resource (13 pages) : color illustrations |
| Collana | ASPE issue brief |
| Soggetto topico |
Generic drugs - Law and legislation - United States
Generic drugs - Prices - United States Drugs - United States - Therapeutic equivalency |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910701236003321 |
| Washington, DC : , : Office of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
| Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2018 |
| Descrizione fisica | 1 online resource (ii, 39 pages) : illustrations |
| Collana | S. hrg. |
| Soggetto topico |
Generic drugs - Prices - United States
Drugs - Prices - United States Prescription pricing - United States Drug accessibility - Government policy - United States Drugs - Generic substitution Drug approval - United States Drug approval Drugs - Prices Generic drugs - Prices Prescription pricing |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Generic drug user fee amendments |
| Record Nr. | UNINA-9910706703803321 |
| Washington : , : U.S. Government Publishing Office, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002
| Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002 |
| Descrizione fisica | 1 online resource (iii, 97 p.) : ill |
| Soggetto topico |
Generic drugs - Prices - United States
Drugs - Prices - United States Pharmaceutical industry - United States Competition - United States |
| Soggetto non controllato |
Generic drugs
Drugs Pharmaceutical industry Competition Medical Business & economics |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Generic pharmaceuticals |
| Record Nr. | UNINA-9910689900003321 |
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
|
The impact of high-priced generic drugs on Medicare and Medicaid
| The impact of high-priced generic drugs on Medicare and Medicaid |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1998 |
| Descrizione fisica | 1 online resource (26 unnumbered pages) : illustrations |
| Soggetto topico |
Medicare - Costs
Medicaid - Costs Generic drugs - Prices - United States Pharmaceutical services insurance - United States Pharmaceutical policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910707393603321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
